Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,691 | 10,840 | 424 | 2 | N/A |
| TOTAL | $2,805 | $10,925 | $424 | $2 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 340 | 93 | N/A | N/A | N/A |
| Other Non-Current Assets | 216 | 316 | 0 | 0 | 0 |
| TOTAL | $556 | $409 | $N/A | $N/A | $N/A |
| Total Assets | $3,362 | $11,334 | $424 | $2 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 24 | N/A | N/A |
| Accounts payable and accrued liabilities | 271 | 397 | 60 | 2 | 0 |
| Accrued Expenses | 803 | 462 | N/A | N/A | N/A |
| TOTAL | $1,118 | $859 | $84 | $2 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $15 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,134 | $859 | $84 | $2 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 738 | 640 | N/A | N/A | N/A |
| Common Shares | 3 | 3 | 1 | N/A | N/A |
| Retained earnings | -14,052 | -3,831 | -118 | -2 | N/A |
| Other shareholders' equity | 0 | 0 | 457 | 2 | 0 |
| TOTAL | $2,228 | $10,475 | $340 | $1 | $N/A |
| Total Liabilities And Equity | $3,362 | $11,334 | $424 | $2 | $0 |